AI is Rewriting The Rules of Real-World Data.
At Artificially Real, we explore how life sciences leaders are using modern AI to turn scattered real-world data into strategic clarity.
The future of insight isn’t coming—it’s already here.
BUILDING SMARTER LIFE SCIENCES LLMS: A SERIES
Introduction – “Building Smarter Life Sciences LLMs” series
New Blog Series Alert: “Building Smarter Life Sciences LLMs”
Life sciences companies are sitting on goldmines of Real World Data—claims, EHRs, patient notes—but struggle to connect the dots. Enter LLMs.
In our new 5-part series, we break down how IT leaders can design and implement enterprise-grade LLM solutions to:
✅ Accelerate evidence generation
✅ Unlock new clinical + commercial insights
✅ Ensure compliance & data privacy
✅ Unify data silos and boost R&D ROI
Whether you’re evaluating use cases or scaling existing AI investments, this is your end-to-end blueprint.
Interlinking Real World Data At Unprecedented Scale
Tthe fragmented and complex nature of RWD—spread across electronic health records (EHRs), claims data, clinical trials, and patient registries—poses significant challenges to effective analysis. Large Language Models (LLMs) are emerging as transformative tools for linking disparate RWD records, enabling life sciences companies to generate deeper insights and accelerate innovation
How AI is Expanding RWD for Clinical Trial Recruitment
Clinical Trials are the backbone of pharmaceutical innovation, driving the engine of development of new safe and efficacious drugs.
Artificial Intelligence (AI) is emerging as a game-changer in patient recruitment. Given the ability to process Real World Data (RWD) and other datasets rapidly, efficiently, and at scale, AI can deliver faster and more extensive data-driven insights. AI can streamline patient recruitment, identifying eligible patients, prioritizing those most suitable for specific trials, and even enhance recruitment efforts, ultimately making the process more efficient and cost-effective.
Innovative Ways AI is Changing Real-World Data Analysis
The explosion of real-world data (RWD) in life sciences, driven by new sources like wearable devices and social media, presents both opportunities and challenges.
Large language models (LLMs) offer a solution by enabling the analysis of vast amounts of structured and unstructured data, particularly in drug discovery, patient recruitment, adverse event detection, and analyzing social determinants of health.
Explore 5 innovative ways LLMs are transforming healthcare and drug development by accelerating innovation and improving patient outcomes.
Enhancing Real-World Data Analysis: How LLMs Enable Advance Data Linkage
The life sciences industry relies heavily on real-world data (RWD) to drive research, improve clinical outcomes, and support regulatory decision-making. However, the fragmented and complex nature of RWD—spread across electronic health records (EHRs), claims data, clinical trials, and patient registries—poses significant challenges to effective analysis. Large Language Models (LLMs) are emerging as transformative tools for linking disparate RWD records, enabling life sciences companies to generate deeper insights and accelerate innovation.
